norethindrone has been researched along with Bone Diseases, Metabolic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beksinska, ME; Farley, TM; Kleinschmidt, I; Rees, HV; Smit, JA | 1 |
| Gold, E; Goulding, A; Stapley, S | 1 |
| Gold, E; Goulding, A | 1 |
| Andreassen, TT; Eschen, C | 1 |
4 other study(ies) available for norethindrone and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception.
Topics: Bone Diseases, Metabolic; Case-Control Studies; Contraceptives, Oral, Combined; Cross-Sectional Studies; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; Time; Young Adult | 2009 |
Tamoxifen and norethisterone: effects on plasma cholesterol and total body calcium content in the estrogen-deficient rat.
Topics: Animals; Bone Diseases, Metabolic; Buserelin; Calcium; Cholesterol; Estradiol; Estrogens; Female; Norethindrone; Rats; Tamoxifen | 1994 |
Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Buserelin; Calcium; Disease Models, Animal; Estradiol; Estrogens; Female; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Rats | 1993 |
Growth hormone normalizes vertebral strength in ovariectomized rats.
Topics: Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Disease Models, Animal; Estradiol; Female; Growth Hormone; Lumbar Vertebrae; Norethindrone; Norethindrone Acetate; Ovariectomy; Rats; Rats, Sprague-Dawley; Tensile Strength | 1995 |